An industry perspective on the US FDA biomarker qualification effort

Mark E Arnold
  • Bioanalysis, June 2018, Future Science
  • DOI: 10.4155/bio-2018-0049

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.4155/bio-2018-0049

In partnership with: